Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.67 USD | +0.43% |
|
+0.32% | +6.44% |
06-26 | Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday | MT |
06-25 | Kiniksa Pharmaceuticals Signs Deal With Samsung Biologics for Arcalyst Supply | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.44% | 1.32B | |
+15.20% | 122B | |
+19.67% | 113B | |
+18.95% | 26.49B | |
-23.86% | 19.4B | |
-19.03% | 16.24B | |
-20.90% | 15.4B | |
-46.14% | 15.15B | |
+63.85% | 14.93B | |
+4.49% | 13.52B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals, Ltd.
- Transcript : Kiniksa Pharmaceuticals, Ltd., Q4 2023 Earnings Call, Feb 28, 2024